| KEGG pathway | −log( value) | Genes |
| ECM-receptor interaction | 55.86 | Col2a1, Col3a1, Col6a3, Col1a1, Col4a4, Col5a2, Col5a3, Col4a1, Col4a3, Col11a1, Col4a2, Col5a1 | Fatty acid degradation | 16.12 | Hadha, Ehhadh, Acadm | Fatty acid metabolism | 9.93 | Hadha, Ehhadh, Acadm | Amoebiasis | 6.21 | Col2a1, Col3a1, Col1a1, Prkx, Col4a4, Col5a2, Col5a3, Col4a1, Col4a3, Col11a1, Col4a2, Col5a1 | Fatty acid elongation | 4.85 | Hadha | Protein digestion and absorption | 3.93 | Col2a1, Col3a1, Col6a3, Col1a1, Col4a4, Col5a2, Col5a3, Col9a1, Col4a1, Col4a3, Col11a1, Atp1b4, Col4a2, Col5a1 | PI3K-Akt signaling pathway | 2.81 | Tsc1.Col2a1.Col3a1.Ddit4.Fgf.Col6a3.Lpar6.Fgf12.Eif4b.Col1a1.Irs1.Them4.Vegfa. Egfr.Ppp2ca.Ghr.Col4a.Tek.Col5a2.Osmr.Ppp2cb.Col5a.Ppp2r3c.Gng5.Col4a1. Col4a.Col11a1.Myb.Gnb3.Col4a.Col5a1.Kit | Tyrosine metabolism | 2.36 | Maoa, ldh1a3 | Other types of O-glycan biosynthesis | 2.23 | Pomt2, Fut9, Colgalt2 | Glycosphingolipid biosynthesis-lacto and neolacto series | 1.81 | B3galt2, Fut9 | Valine, leucine and isoleucine degradation | 1.81 | Hadha, Ehhadh, Acadm | Focal adhesion | 1.41 | Col2a1.Col3a1.Vav3.Col6a3.Col1a1.Vegfa.Crkl.Egfr.Col4a.Col5a2.Col5a3.Mylk. Col4a1.Col4a3.Col11a1.Col4a2.Col5a1.Ppp1ccsee interacti |
|
|